Association of G-protein coupled purinergic receptor P2Y2 with ischemic stroke in a Han Chinese population of North China

被引:0
|
作者
Li-Ying Yuan [1 ]
Zhi-Yi He [1 ]
Lei Li [1 ]
Yan-Zhe Wang [1 ]
机构
[1] Department of Neurology, First Affiliated Hospital of China Medical University
基金
中国国家自然科学基金;
关键词
nerve regeneration; P2RY2; gene; ischemic stroke; single nucleotide polymorphism; case-control study; haplotype; northern Han Chinese population; large-artery atherosclerosis; small-artery occlusion; hypertension; candidate gene; neural regeneration;
D O I
暂无
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
1002 ;
摘要
The G-protein-coupled purinergic receptor P2Y2(P2RY2) plays an important role in the mechanism of atherosclerosis, which is relevant to ischemic stroke. This retrospective case-control study aimed to assess the relationship between P2RY2 gene polymorphisms and ischemic stroke risk in the northern Han Chinese population. In this study, clinical data and peripheral blood specimens were collected from 378 ischemic stroke patients and 344 controls. The ischemic stroke participants were recruited from the First Affiliated Hospital of China Medical University and the First Affiliated Hospital of Liaoning Medical University. The controls were recruited from the Health Check Center at the First Affiliated Hospital of China Medical University. Ischemic stroke patients were divided into two subgroups according to the Trial of ORG 10172 in Acute Stroke Treatment(TOAST) classification: large-artery atherosclerosis(n = 178) and small-artery occlusion(n = 200) strokes. All subjects were genotyped for three single nucleotide polymorphisms(rs4944831, rs1783596, and rs4944832) in the P2RY2 gene using peripheral venous blood samples. The distribution of the dominant rs4944832 phenotype(GG vs. GA+AA) differed significantly between small-artery occlusion patients and control subjects(odds ratio(OR) = 1.720, 95% confidence interval(CI): 1.203–2.458, P < 0.01). Multivariable logistic regression analysis revealed that the GG genotype of rs4944832 was significantly more prevalent in small-artery occlusion patients than in control subjects(OR = 1.807, 95% CI: 1.215–2.687, P < 0.01). The overall distribution of the haplotype established by rs4944831-rs1783596-rs4944832 was significantly different between ischemic stroke patients and controls(P < 0.01). In ischemic stroke patients, the frequency of the G-C-G haplotype was significantly higher than in control subjects(P = 0.028), whereas the frequency of the T-C-A haplotype was lower than in control subjects(P = 0.047). These results indicate that the G-C-G haplotype of P2RY2 is a susceptibility haplotype for ischemic stroke. In addition, the GG genotype of rs4944832 may be associated with the development of small-artery occlusion in the northern Han Chinese population. The study protocol was approved by the Ethics Committee of the First Affiliated Hospital of China Medical University on February 20, 2012(No. 2012-38-1) and the First Affiliated Hospital of Liaoning Medical University, China, on March 1, 2013(No. 2013-03-1). All participants gave their informed consent. This trial was registered with the ISRCTN Registry(ISRCTN11439124) on October 24, 2018. Protocol version(1.0).
引用
收藏
页码:506 / 512
页数:7
相关论文
共 50 条
  • [21] Bone turnover is altered in transgenic rats overexpressing the P2Y2 purinergic receptor
    Maria Ellegaard
    Cansu Agca
    Solveig Petersen
    Ankita Agrawal
    Lars Schack Kruse
    Ning Wang
    Alison Gartland
    Jens-Erik Beck Jensen
    Niklas Rye Jørgensen
    Yuksel Agca
    Purinergic Signalling, 2017, 13 : 545 - 557
  • [22] Association between C-Reactive Protein Genes and Ischemic Stroke in a Chinese Han population of mainland China
    Guo, J.
    Yu, L. H.
    Zhou, M. K.
    Zhang, J. J.
    Zhao, J. J.
    Chen, N.
    Xu, Y. M.
    He, L.
    CEREBROVASCULAR DISEASES, 2013, 35 : 425 - 425
  • [23] Bone turnover is altered in transgenic rats overexpressing the P2Y2 purinergic receptor
    Ellegaard, Maria
    Agca, Cansu
    Petersen, Solveig
    Agrawal, Ankita
    Kruse, Lars Schack
    Wang, Ning
    Gartland, Alison
    Jensen, Jens-Erik Beck
    Jorgensen, Niklas Rye
    Agca, Yuksel
    PURINERGIC SIGNALLING, 2017, 13 (04) : 545 - 557
  • [24] Genetic polymorphisms of purinergic P2Y2 receptor were associated with the susceptibility to essential hypertension in Chinese postmenopausal women
    Li, Ao
    Xiong, Chaopeng
    Gong, Chengxin
    Gou, Mengyang
    Wang, Yaqun
    Yang, Yuping
    Xu, Hong
    PURINERGIC SIGNALLING, 2023, 19 (04) : 663 - 671
  • [25] Genetic polymorphisms of purinergic P2Y2 receptor were associated with the susceptibility to essential hypertension in Chinese postmenopausal women
    Ao Li
    Chaopeng Xiong
    Chengxin Gong
    Mengyang Gou
    Yaqun Wang
    Yuping Yang
    Hong Xu
    Purinergic Signalling, 2023, 19 : 663 - 671
  • [26] Negative regulation of Ca2+ influx during P2Y2 purinergic receptor activation is mediated by Gβγ-subunits
    Hu, Haibi
    O'Mullane, Lauren M.
    Cummins, Michelle M.
    Campbell, Craig R.
    Hosoda, Yutaka
    Poronnik, Philip
    Dinudom, Anuwat
    Cook, David I.
    CELL CALCIUM, 2010, 47 (01) : 55 - 64
  • [27] G protein-coupled purinergic P2Y receptor oligomerization: Pharmacological changes and dynamic regulation
    Guo, Xiaoqing
    Li, Qin
    Pi, Shulan
    Xia, Yuanpeng
    Mao, Ling
    BIOCHEMICAL PHARMACOLOGY, 2021, 192
  • [28] Inhibition of G protein-coupled P2Y2 receptor induced analgesia in a rat model of trigeminal neuropathic pain
    Li, Na
    Lu, Zhan-ying
    Yu, Li-hua
    Burnstock, Geoffrey
    Deng, Xiao-ming
    Ma, Bei
    MOLECULAR PAIN, 2014, 10
  • [29] Intestinal inflammation up-regulates the expression of the G protein-coupled receptor P2Y2 at the transcriptional level
    Degagne, Emilie
    Grbic, Djordje
    Lavoie, Elyse
    Dupuis, Andree-Anne
    Sevigny, Jean
    Gendron, Fernand-Pierre
    PURINERGIC SIGNALLING, 2008, 4 : S182 - S182
  • [30] G protein-coupled purinergic P2Y receptors in infectious diseases
    Carvalho, Leticia de Almeida
    Alves, Vinicius Santos
    Coutinho-Silva, Robson
    Baggio Savio, Luiz Eduardo
    PHARMACOLOGY & THERAPEUTICS, 2025, 267